Please read about the progress towards our shared vision: of a future without Duchenne muscular dystrophy, made throughout the past three years, all made possible by our loving, dedicated supporters.
Continue readingHelp shape the work of Defeat Duchenne Canada over the next five years by sharing your feedback. Complete a short strategic planning survey, and you could WIN a $200 Amazon gift card!
Continue readingThe Chair of the Board of Directors announces an important update regarding the leadership of Defeat Duchenne Canada.
Continue reading
Defeat Duchenne Canada and Muscular Dystrophy Canada created a community statement regarding the latest supply issues of Deflazacort.
Continue reading
Defeat Duchenne Canada is delighted to announce that the sponsored Canadian clinical trial of vamorolone has reached a key milestone (trial midpoint) of opening higher dose treatment groups to new enrollment.
Continue reading
The Canadian Organization for Rare Disorders (CORD) has created an open letter asking the government to commit dedicated funds to support the establishment of networks of Centres of Excellence across Canada.
Continue reading
Our Founder and celebrated Canadian, John Davidson, received an honorary doctorate of laws from Western University.
Continue reading
Defeat Duchenne Canada, Canada’s leader in Duchenne muscular dystrophy-funded research, is proud to announce that it will grant $1.14M toward three promising research projects this year – making the total awarded over its 27-year history $16M.
Continue reading
The 2022 Virtual Walk to Defeat Duchenne saw 400 participants from across Canada and beyond (the largest number of participants in Walk history!), raising $224,198 to defeat Duchenne muscular dystrophy.
Continue reading
Defeat Duchenne Canada has developed an innovative Clinical Trial Finder Tool that helps gather comprehensive information on existing and pending clinical trials for individuals and families living with Duchenne or Becker muscular dystrophy.
Continue reading